Keith Loria

Provider networks are a fundamental part of U.S. health insurance. But an increasing number of self-insured employers are offering low-premium health plans without networks, and the CMS is working toward having such plans available on the ACA marketplaces.

The resistome is the term for resistance genes present in both harmful and nonharmful bacteria. In the lung, this genetic reservoir can be shaped by factors such as repeated antibiotic exposure, chronic inflammation and changes in the airway environment.

The pulmonary manifestations of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis is well recognized. This research fills in gaps about the prevalence and prognostic impact of interstitial lung disease in people with the autoimmune disease.

The investigators applied a multinomial statistical model to evaluate associations between individual CT features and final radiologic diagnoses.

A study published March 20 in Nature found that a mechanosensitive piezo1–IL-33 signaling pathway in vascular endothelial cells is associated with pulmonary fibrosis and may represent a potential therapeutic target.

Researchers found that lung function showed only a weak relationship with quality-of-life outcomes, highlighting perhaps the value of broader patient-reported or caregiver-reported outcomes in clinical care and research.

Researchers find that inpatient utilization was 53% higher among patients with exacerbations.

The researchers caution, though, that causality cannot be inferred from the association found in an observational study.

A number of recent studies suggests that shingles vaccine has benefits beyond just protecting against shingles.

A team of Researchers developed a "recovery index" that integrates three factors related to the six-minute walk test.

Stereotactic ablative radiotherapy, also referred to as stereotactic body radiation therapy, has emerged as a standard noninvasive treatment alternative, offering high local control rates with relatively limited toxicity in carefully selected patients.

Because familial idiopathic pulmonary fibrosis is associated with earlier onset and worse outcomes, there are questions about the effectiveness of the antifibrotics as a treatment.

Several lines of evidence suggest that testing the traditional drug for diabetes might benefit people with idiopathic pulmonary fibrosis.

The findings challenge the conventional view that daytime sleepiness is always a result of insufficient sleep, poor sleep hygiene or classic sleep disorders.

Researchers used nanoparticle technology to encapsulate paclitaxel and target bladder tumors more effectively. Early results demonstrate tumor elimination and minimal side effects.

The new radiotracer takes advantage of two biological targets linked to fibrotic and inflammatory processes in the lung: fibroblast activation protein and integrin receptors.

Researchers found that participants with excessive daytime sleepiness had significantly lower maximum tongue pressure, poorer chewing performance and diminished swallowing function.

New study shows catheter ablation significantly was associated with a 40% drop in major cardiovascular events and a 70% decline in all-cause mortality for patients with both atrial fibrillation and obstructive sleep apnea.

Given the long latency and broad spectrum of respiratory conditions associated with military deployment, the findings underscore the need for long-term medical surveillance and specialized respiratory care for veterans.

The AI-powered imaging technology quantifies the extent of fibrosis on CT scans and also measures other features, such as ground-glass opacification.

Early-stage research suggests a strategy for suppressing bladder cancer growth at the RNA level.

New technology generates “nanotube highways” between cancer cells, enabling better drug penetration and tumor-killing effectiveness while minimizing harm to surrounding healthy tissue in animal studies of bladder cancer.

Kates, a nationally recognized expert on bladder cancer, lends credibility to the company’s efforts to develop a new treatment for bladder cancer.